KAM
ALXN
Krensavage Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-6,912
| Closed | -$1.06M | – | 14 |
|
|
2021
Q1 | $1.06M | Sell |
6,912
-357,362
| -98% | -$54.6M | 0.37% | 10 |
|
|
2020
Q4 | $56.9M | Sell |
364,274
-32,301
| -8% | -$5.05M | 16.62% | 1 |
|
|
2020
Q3 | $45.4M | Sell |
396,575
-96,595
| -20% | -$11.1M | 14.45% | 2 |
|
|
2020
Q2 | $55.4M | Buy |
493,170
+31,032
| +7% | +$3.48M | 15.06% | 2 |
|
|
2020
Q1 | $41.5M | Buy |
462,138
+148,582
| +47% | +$13.3M | 13.35% | 3 |
|
|
2019
Q4 | $33.9M | Buy |
313,556
+58,556
| +23% | +$6.33M | 11.57% | 4 |
|
|
2019
Q3 | $25M | Buy |
+255,000
| New | +$25M | 9.59% | 6 |
|